Document is current
Any future updates will be listed below
-
Authors
Oduwole, O.
Ding, C.
Bitar, N.
Nair, D.
Salter, S.
Silverman, M.
Allen, R.
Ng Fat, L.
Tsochatzis, E.
Bell, S.
Mehta, G.
Britton, A.
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (PB-PG-0418-20038, PB-PG-0418-20038, PB-PG-0418-20038, PB-PG-0418-20038, PB-PG-0418-20038)
- License Information
-
More Information
Article History
Received: 14 December 2024
Accepted: 6 April 2025
First Online: 5 May 2025
Competing interests
: GM has shares in Hepyx Limited and Yaqrit Limited, which are involved in liver disease therapeutics. GM is an inventor of ‘Treatment of Pyroptosis in Liver Disease’ (Patent filing: US20210069296A1; EP19721333.3A). The remaining authors declare no competing interests.
